PDE10 inhibitor

This page covers all PDE10 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PDE10A.

Targets

PDE10A

Phase 3 pipeline (1)

• PP1M · Janssen Research & Development, LLC · Neurology/Psychiatry
  PP1M is a phosphodiesterase 10 (PDE10) inhibitor that increases intracellular cyclic nucleotide levels to modulate neuronal signaling.